Etoposide
NDC 68001-683, Etoposide, injection, solution, concentrate, from BluePoint Laboratories.
- Product NDC
- 68001-683
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074529
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-683 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETOPOSIDE20 mg/mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-683-27 | 68001068327 | 1 VIAL, MULTI-DOSE in 1 CARTON (68001-683-27) / 50 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0dddbe44-b4f4-431f-9011-8a54abbd4cbfMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68001-683
Use it
Look up 68001-683 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-683 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-683. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.